Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Agranulocytosis D000380 7 associated lipids
Albuminuria D000419 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Amnesia D000647 12 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Hypoxia D000860 23 associated lipids
Anthrax D000881 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthus Reaction D001183 8 associated lipids
Ascites D001201 25 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Zhang GQ et al. [The effects of milkvetch and memantain on the synthesis of cerebral PAF in neonatal rats with hypoxic-ischemic reperfusion]. 2003 Zhonghua Er Ke Za Zhi pmid:14751060
Mayerle J et al. [Conservative treatment of acute pancreatitis]. 2003 Med. Klin. (Munich) pmid:14685675
Tellis C et al. Localization of an alkyl-acetyl-glycerol-CDP-choline: cholinephosphotransferase activity in submitochondrial fractions of Tetrahymena pyriformis. 2003 Eur. J. Cell Biol. pmid:14703014
Stafforini DM et al. Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. 2003 Crit Rev Clin Lab Sci pmid:14708958
Narahara H et al. Platelet-activating factor inhibits the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages. 2003 J. Clin. Endocrinol. Metab. pmid:14671207
Gálvez J et al. The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through downregulation of cytokine production. 2003 Inflamm. Bowel Dis. pmid:14671485
Saeed SA and Rasheed H Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation. 2003 Acta Pharmacol. Sin. pmid:12511226
Ishizuka S et al. Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells. 2003 J. Infect. Dis. pmid:14673774
Koyama N Platelet activating factor in surfactant-TA is inhibited by coexisting inhibitors. 2003 Lung pmid:14692561
Zhang Y et al. Antioxidant superoxide dismutase attenuates increased endothelial permeability induced by platelet-activating factor. 2003 J. Soc. Gynecol. Investig. pmid:12517587
Zhu X et al. Structural determinants of blockade of eosinophil activation, adhesion and secretion by synthetic analogs of phomactin. 2003 Life Sci. pmid:14519449
Hu H et al. Glycoprotein IIb/IIIa inhibition attenuates platelet-activating factor-induced platelet activation by reducing protein kinase C activity. 2003 J. Thromb. Haemost. pmid:12911597
Kalia N and Bardhan KD Of blood and guts: association between Helicobacter pylori and the gastric microcirculation. 2003 J. Gastroenterol. Hepatol. pmid:12911655
Tokuoka SM et al. Involvement of platelet-activating factor and LIS1 in neuronal migration. 2003 Eur. J. Neurosci. pmid:12911752
Lupia E et al. Intra-plaque production of platelet-activating factor correlates with neoangiogenesis in human carotid atherosclerotic lesions. 2003 Int. J. Mol. Med. pmid:12883648
Handa RK et al. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo. 2003 Kidney Blood Press. Res. pmid:12886044
Taggart DP et al. Neuroprotection during cardiac surgery: a randomised trial of a platelet activating factor antagonist. 2003 Heart pmid:12860868
Takafuji S et al. Matrix metalloproteinase-9 release from human leukocytes. 2003 J Investig Allergol Clin Immunol pmid:12861851
Bar-Or D et al. Copper stimulates the synthesis and release of interleukin-8 in human endothelial cells: a possible early role in systemic inflammatory responses. 2003 Shock pmid:12865660
Kujiraoka T et al. Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus. 2003 J. Lipid Res. pmid:12867534
D'Andrea D et al. Induction of tissue factor in the arterial wall during recurrent thrombus formation. 2003 Arterioscler. Thromb. Vasc. Biol. pmid:12869352
Lupia E et al. The membrane attack complex of complement contributes to plasmin-induced synthesis of platelet-activating factor by endothelial cells and neutrophils. 2003 Immunology pmid:12871223
Fernandes ES et al. Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of kinin B1 receptors in the rat paw. 2003 Br. J. Pharmacol. pmid:12839871
Saruc M et al. An experimental model of hemolysis-induced acute pancreatitis. 2003 Braz. J. Med. Biol. Res. pmid:12845374
Nomikos TN et al. Acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (lyso-PAF AT) activity in cortical and medullary human renal tissue. 2003 Eur. J. Biochem. pmid:12846832
Suzuki M et al. Actin assembly is a crucial factor for superoxide anion generation from adherent human eosinophils. 2003 J. Allergy Clin. Immunol. pmid:12847489
Rios-Santos F et al. A critical role of leukotriene B4 in neutrophil migration to infectious focus in cecal ligaton and puncture sepsis. 2003 Shock pmid:12558146
Lukashova V et al. Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): roles of Tyk2 and PAFR C terminus. 2003 J. Immunol. pmid:14500680
Brandt EB et al. Mast cells are required for experimental oral allergen-induced diarrhea. 2003 J. Clin. Invest. pmid:14660743
Rhee CK Candidate's thesis: Platelet-activating factor-induced hearing loss: mediated by nitric oxide? 2003 Laryngoscope pmid:14660903
Diaper CM et al. A total synthesis of (+/-)-phomactin A. 2003 Org. Biomol. Chem. pmid:14664384
Beck-Speier I et al. Sulfur-related air pollutants induce the generation of platelet-activating factor, 5-lipoxygenase- and cyclooxygenase-products in canine alveolar macrophages via activation of phospholipases A2. 2003 Prostaglandins Other Lipid Mediat. pmid:14518563
Antonopoulou S et al. Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients. 2003 Mediators Inflamm. pmid:14514473
Kusunoki H et al. Relation between serum 3-deoxyglucosone and development of diabetic microangiopathy. 2003 Diabetes Care pmid:12766129
Gödecke A PAF, PIP(3) and NO: emerging role in reperfusion injury. 2003 Cardiovasc. Res. pmid:14613846
Strümper D et al. Effects of antidepressants on function and viability of human neutrophils. 2003 Anesthesiology pmid:12766643
Alloatti G et al. Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility. 2003 Cardiovasc. Res. pmid:14613853
Pizurki L et al. Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production. 2003 Br. J. Pharmacol. pmid:12770938
Akisu M et al. Supplementation with Saccharomyces boulardii ameliorates hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice. 2003 Eur J Pediatr Surg pmid:14618522
Proudfoot JM et al. Angiotensin II type 1 receptor antagonists inhibit basal as well as low-density lipoprotein and platelet-activating factor-stimulated human monocyte chemoattractant protein-1. 2003 J. Pharmacol. Exp. Ther. pmid:12626661
Fang HY et al. Cyclooxygenase-2 in human non-small cell lung cancer. 2003 Eur J Surg Oncol pmid:12633561
Cole KP and Hsung RP Intramolecular formal oxa-[3 + 3] cycloaddition approach to the ABD system of phomactin A. 2003 Org. Lett. pmid:14653688
Hao J et al. [Dynamic changes of platelet number in early multiple injury and it is effect on prognosis]. 2003 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:14552687
Witko-Sarsat V et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. 2003 Kidney Int. pmid:12787398
Elovitz MA et al. A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. 2003 Am. J. Pathol. pmid:14578208
Slomiany BL and Slomiany A Platelet-activating factor modulates gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. 2003 Biochem. Biophys. Res. Commun. pmid:12788098
Kogure K et al. Temporary membrane distortion of vascular smooth muscle cells is responsible for their apoptosis induced by platelet-activating factor-like oxidized phospholipids and their degradation product, lysophosphatidylcholine. 2003 Chem. Phys. Lipids pmid:14580708
Schuster DP et al. Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial. 2003 Crit. Care Med. pmid:12794395
Rabinovici R Platelet activating factor inhibition in sepsis: the end? 2003 Crit. Care Med. pmid:12794432
Bernatchez PN et al. Sphingosine 1-phosphate effect on endothelial cell PAF synthesis: role in cellular migration. 2003 J. Cell. Biochem. pmid:14587028
Saraf MK et al. Role of platelet activating factor in triazolobenzodiazepines-induced retrograde amnesia. 2003 Behav. Brain Res. pmid:12798263
Denizot Y et al. Platelet-activating factor and normal or leukaemic haematopoiesis. 2003 Leuk. Lymphoma pmid:12802913
Olanders K et al. Protective effects of N-acetyl-L-cysteine and platelet activating factor inhibition are not linked to intercellular adhesion molecule-1 expression after intestinal ischemia and reperfusion injury in rats. 2003 Scand. J. Gastroenterol. pmid:12825870
Adamson RH et al. PAF- and bradykinin-induced hyperpermeability of rat venules is independent of actin-myosin contraction. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12649070
Haraldsen P et al. Multimodal management - of value in fulminant acute pancreatitis? 2003 Pancreatology pmid:12649560
Li XG and Luo HM [Progress in studies of chemical constituents and pharmacological activities of Kadsura]. 2003 Zhongguo Zhong Yao Za Zhi pmid:15617488
Denizot Y et al. No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis. 2003 Mediators Inflamm. pmid:12775360
Yan W et al. Previously uncharacterized roles of platelet-activating factor acetylhydrolase 1b complex in mouse spermatogenesis. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12775763
Nie ZG and Wang WJ [Effect of ginkgolide B on platelet-activating factor induced activation of rat polymorphonuclear leukocytes]. 2003 Yao Xue Xue Bao pmid:12778742
Fragopoulou E et al. Structure elucidation of phenolic compounds from red/white wine with antiatherogenic properties. 2003 Biochim. Biophys. Acta pmid:12782155
Marshall JC Such stuff as dreams are made on: mediator-directed therapy in sepsis. 2003 Nat Rev Drug Discov pmid:12750742
Bayar MA et al. The effect of EGb-761 on morphologic vasospasm in canine basilar artery after subarachnoid hemorrhage. 2003 J. Cardiovasc. Pharmacol. pmid:12960685
Kato M et al. The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis. 2003 J Ocul Pharmacol Ther pmid:12964956
Ishiura Y et al. Airway eosinophil accumulation on sensory neuropeptide release in a guinea pig model of distilled-water-induced bronchoconstriction. 2003 J Investig Allergol Clin Immunol pmid:12968390
Calabresi L et al. Endothelial protection by high-density lipoproteins: from bench to bedside. 2003 Arterioscler. Thromb. Vasc. Biol. pmid:12969988
Mariano F et al. Platelet-activating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production. 2003 Shock pmid:12688545
Thaete LG et al. Infusion of exogenous platelet-activating factor produces intrauterine growth restriction in the rat. 2003 J. Soc. Gynecol. Investig. pmid:12699876
Simon HU et al. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome. 2003 Eur. J. Immunol. pmid:12672048
Teather LA and Wurtman RJ Cyclooxygenase-2 mediates platelet-activating factor-induced prostaglandin E2 release from rat primary astrocytes. 2003 Neurosci. Lett. pmid:12672535
Kordan W et al. Functions of platelet activating factor (PAF) in mammalian reproductive processes: a review. 2003 Pol J Vet Sci pmid:12675470
Loucks EB et al. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart. 2003 Can J Cardiol pmid:12677282
Ginesta MM et al. Modulation of the pathology of late xenograft rejection by PAF-antagonist UR-12670 in the hamster-to-rat liver xenotransplant model. 2003 APMIS pmid:12752216
Peri A et al. The effects of an autocrine loop mediated by platelet-activating factor (PAF) in HEC-1A cells are reverted by uteroglobin. 2003 Hum. Cell pmid:15005239
Wu B et al. Platelet-activating factor promotes mucosal apoptosis via FasL-mediating caspase-9 active pathway in rat small intestine after ischemia-reperfusion. 2003 FASEB J. pmid:12709415
Ueda Y et al. Effects on blood pressure decrease in response to PAF of Impatiens textori MIQ. 2003 Biol. Pharm. Bull. pmid:14519965
Akisu M et al. The role of dietary supplementation with L-glutamine in inflammatory mediator release and intestinal injury in hypoxia/reoxygenation-induced experimental necrotizing enterocolitis. 2003 Ann. Nutr. Metab. pmid:14520021
Bussolati B et al. The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells. 2003 J. Immunol. pmid:12538709
Frostegård J et al. Antibodies against platelet-activating factor and platelet-activating factor-like lipids are raised in women with primary recurrent abortion. 2003 Am. J. Obstet. Gynecol. pmid:14520236
Ahlemeyer B and Krieglstein J Neuroprotective effects of Ginkgo biloba extract. 2003 Cell. Mol. Life Sci. pmid:14523543
Hirayama K et al. Platelet-activating factor, a critical mediator in the pathogenesis of dextran sulfate sodium-induced colitis in rats. 2003 Dis. Colon Rectum pmid:12544529
Balestrieri ML et al. Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress. 2003 J. Lipid Res. pmid:12576520
Lee JM et al. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. 2003 J. Biol. Chem. pmid:12556532
Handa RK et al. Platelet-activating factor and solute transport processes in the kidney. 2003 Am. J. Physiol. Renal Physiol. pmid:12529272
Biancone L et al. Platelet-activating factor inactivation by local expression of platelet-activating factor acetyl-hydrolase modifies tumor vascularization and growth. 2003 Clin. Cancer Res. pmid:14519648
Chen L et al. [Determination of platelet activating factor in middle ear effusion of patients with secretory oitits media]. 2003 Lin Chuang Er Bi Yan Hou Ke Za Zhi pmid:14727433
Dinarello CA The IL-1 family and inflammatory diseases. 2002 Sep-Oct Clin. Exp. Rheumatol. pmid:14989423
Chłopicki S et al. Hypoxic pulmonary vasoconstriction in isolated blood-perfused rat lung; modulation by thromboxane A2, platelet-activating factor, cysteinyl leukotrienes and endothelin-1. 2002 Sep-Oct Pol J Pharmacol pmid:12593530
Klabunde RE and Anderson DE Role of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvascular leakage. 2002 May-Jun J. Vasc. Res. pmid:12097822
Huang JB et al. Hexokinase translocation during neutrophil activation, chemotaxis, and phagocytosis: disruption by cytochalasin D, dexamethasone, and indomethacin. 2002 Jul-Aug Cell. Immunol. pmid:12470617
Levine AS et al. A review of the effect of platelet-activating factor on male reproduction and sperm function. 2002 Jul-Aug J. Androl. pmid:12065449
Farbiszewski R et al. [The role of platelet activating factor (PAF) in physiology and pathology of the central nervous system]. 2002 Jul-Aug Neurol. Neurochir. Pol. pmid:12418143
Chang HW et al. Platelet-activating factor acetylhydrolase activity in cerebrospinal fluid of children with acute systemic or neurological illness. 2002 Ann. Neurol. pmid:12112082
Ewer AK Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis. 2002 Acta Paediatr Suppl pmid:12200892
Göggel R et al. Platelet-activating factor-induced pulmonary edema is partly mediated by prostaglandin E(2), E-prostanoid 3-receptors, and potassium channels. 2002 Am. J. Respir. Crit. Care Med. pmid:12204861
Zimmerman GA et al. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. 2002 Crit. Care Med. pmid:12004251
Silva AR et al. Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein. 2002 J. Immunol. pmid:11937571
Leung SW et al. Platelet-activating factor enhanced the pressor response of endothelin-1. 2002 J. Cardiovasc. Pharmacol. pmid:12352314
Brewer C et al. Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor. 2002 J. Neurochem. pmid:12354298
Ueyama Y et al. Effects of bile acids on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced aberrant crypt foci and DNA adduct formation in the rat colon. 2002 J. Exp. Clin. Cancer Res. pmid:12636105
Ohshima N et al. Receptor-dependent metabolism of platelet-activating factor in murine macrophages. 2002 J. Biol. Chem. pmid:11786559